Dr. Quan Dong Nguyen presents interim data from the phase 3 DRAGON study on a potential first therapy for adolescent Stargardt disease.
Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS
Advertisement
Articles by Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Altered ipRGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer’s disease
2
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
3
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice
4
Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence
5